Gyros Protein Technologies and Cygnus Technologies expand collaboration
July 8, 2021Gyros Protein has announced the next phase of its on-going collaboration with Cygnus Technologies alongside the introduction of a new …
New screening method set to speed up drug discovery in major diseases
July 8, 2021drug discovery
Scientists from the University of Birmingham and the University of Leicester have discovered a new screening method that can test …
WHO recommends Roche and Sanofi treatments to cut COVID-19 death risk
July 8, 2021The WHO has recommended using arthritis drugs Actemra from Roche and Kevzara from Sanofi with corticosteroids for COVID-19 patients. This …
Mass COVID testing reduces cases by a fifth study shows
July 7, 2021Research and Development COVID-19 testing, COVID-19. testing, lateral flow tests, liverpool
A pilot study conducted by the University of Liverpool has found that mass rapid testing reduced COVID-19 cases in Liverpool …
First ex vivo human skin platform investigating ISR launched
July 7, 2021Research and Development
Genoskin has announced the launch of ISR Platform, a novel pre-clinical toolbox designed to study injection site reactions (ISR) in …
Summer COVID cases set to reach 2 million with 10 million isolating
July 7, 2021Research and Development COVID-19, Lockdown, UK, Vaccine, government
Analysis from the Guardian has found that over two million people could contract COVID-19 this summer, which could therefore lead …
EU orders nearly 40 million more J&J COVID vaccines
July 7, 2021Research and Development
The EU has ordered nearly 40 million more doses of the J&J COVID-19 vaccines for European countries. This is despite …
Breakthrough heart failure drug meets primary endpoint
July 7, 2021Research and Development
The Phase III trial for empagliflozin, a treatment for patients with heart failure with preserved ejection fraction, has met its …
Pfizer’s COVID-19 vaccine efficacy falls to 64% in Israel
July 6, 2021Manufacturing and Production
Israel has reported a decrease to 64% in the effectiveness of the Pfizer-BioNTech COVID-19 vaccine in preventing infections and symptomatic …
UVC light found to inactivate COVID virus in study
July 6, 2021Manufacturing and Production COVID-19, clinical trials, computer simulations, skin
A new study has found that Ultraviolet C (UVC) emitting lamps are fast, effective, and safe at inactivating SARS-CoV-2, the …
Sosei and InveniAI to collaborate on AI-powered drug discovery
July 6, 2021Manufacturing and Production
Sosei Heptares and InveniAI have entered a multi-target AI-powered and GPCR-focused drug discovery collaboration. The two companies will combine InveniAI’s …
Novel cancer therapy kick starts clinical trials
July 6, 2021Manufacturing and Production oncology
The first patient has been dosed in Phase 1/2 trials investigating a new form of cancer therapy, gamma delta TCR …
MIMETAS and Roche to collaborate on drug development
July 6, 2021Manufacturing and Production
MIMETAS and Roche have entered into a collaboration to develop human disease models to characterise novel compounds in inflammatory bowel …
Over 600,000 positive COVID tests genomically sequenced in UK
July 5, 2021Sales and Marketing COVID-19, Delta variant, UK, government, variant
The UK has genomically sequenced more than 600,000 positive COVID-19 test, it was announced on Friday. Genomic sequencing plays a …
Strawberry-flavoured tablet distributed to children with HIV
July 5, 2021Sales and Marketing
A strawberry-flavoured generic HIV drug has been distributed in Africa for children and babies living with HIV. The drug, which …
Visitors with non-EU approved jabs allowed in Madeira
July 5, 2021Sales and Marketing COVID-19, EU, Vaccine, travel
Popular holiday destination, the Portuguese islands of Madeira, have announced that they will allow visitors with any COVID-19 vaccine, even …
BioMed X and Merck launch new Oncology research programme
July 5, 2021Sales and Marketing
BioMed X and Merck have launched a new joint research programme in oncology. The new program will explore the role …
South Korea in talks to produce one billion mRNA vaccine doses
July 5, 2021Sales and Marketing
South Korea is in talks with mRNA vaccine makers, including Pfizer-BioNtech and Moderna, to produce up to one billion COVID-19 …
AstraZeneca MPO inhibitor shows promise for heart failure patients
July 2, 2021Medical Communications
Results released from AstraZeneca’s Phase IIa SATELLITE trial demonstrated that AZD4831, a myeloperoxidase (MPO) inhibitor, achieved pre-specified target engagement in …
Congenital adrenal hyperplasia treatment granted MHRA authorisation
July 2, 2021Medical Communications
The MHRA has granted marketing authorisation to Diurnal’s treatment, Efmody, as treatment of adult and adolescent patients with the rare …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
